Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK.

Orphanet journal of rare diseases - 16 Sept 2008

Moore David, Connock Martin J, Wraith Ed, Lavery Christine

Abstract excerpt

BACKGROUND: Mucopolysaccharidosis type I (MPS I) is a rare lysosomal storage disease subdivided into three phenotypes of increasing severity: Scheie, Hurler-Scheie and Hurler. To gauge the effectiveness of treatments and to determine the load likely to fall on health-care systems, it is necessary to understand the prevalence and natural progression of the disease especially with regard to life-expectancy. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Demography
Share to England
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mucopolysaccharidosis I

Share to Prevalence

Share to Registries

Share to Societies, Medical

Source

Open in PubMed Open full text

Identifiers

PMID: 18796143
DOI: 10.1186/1750-1172-3-24
PMCID: PMC2553763

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK.PMID 18796143Read ↗

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.Semantic proximity Read ↗

The natural history of MPS I: global perspectives from the MPS I Registry.Semantic proximity Read ↗

Mucopolysaccharidosis Type ISemantic proximity Read ↗

Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic.Semantic proximity Read ↗

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseSemantic proximity Read ↗

Growth patterns for untreated individuals with MPS I: Report from the international MPS I registry.Semantic proximity Read ↗

MPS I: Early diagnosis, bone disease and treatment, where are we now?Semantic proximity Read ↗

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.Semantic proximity Read ↗

A Review Of The Clinical Outcomes In Idursulfase-Treated And Untreated Filipino Patients With Mucopolysaccharidosis Type II: Data From The Local Lysosomal Storage Disease RegistrySemantic proximity Read ↗

Epidemiology of Mucopolysaccharidoses UpdateSemantic proximity Read ↗

Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)Semantic proximity Read ↗

Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.